Skip to main content
Clinical Trials/CTRI/2025/08/093253
CTRI/2025/08/093253Not yet recruitingPhase 2/3

Effect of Talamuli (Curculigo orchioides Gaertn.) choorna with Go ksheera (Cow’s milk) in Perimenopausal symptoms.

Rinsha Shareef1 site in 1 country27 target enrollmentStarted: September 9, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
27
Locations
1
Primary Endpoint
Changes in the level of symptoms are assessed as outcome variables as per the Greene Climacteric Scale.

Study Overview

Brief Summary

The above study deals with the effect of Talamuli choorna with Go ksheera in managing Perimenopausal symptoms which is assessed as per the Greene Climacteric Scale. The study also aims to evaluate the pharmacognostical, phytochemical, HPTLC and Ayurvedic parameters of Talamuli rhizome and Talamuli choorna. Patients in the 40-55 years coming under the inclusion ciriteria will be administered Talamuli choorna orally in the dose of 3 gm with125 ml cow’s milk twice daily(7 am and 7 pm) before food for a duration of 30 days.Assessment will be done pre and post treatment based on the Greene Climacteric Scale.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
40.00 Year(s) to 55.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Females diagnosed to have perimenopausal symptoms as per the Greene Climacteric Scale.
  • Greene Climacteric scale score above
  • Patients willing to give written consent.

Exclusion Criteria

  • Surgical menopause.
  • Any known case of malignancy.
  • Psychiatric disorders.
  • Uncontrolled chronic and systemic illness.

Outcomes

Primary Outcomes

Changes in the level of symptoms are assessed as outcome variables as per the Greene Climacteric Scale.

Time Frame: Changes in the level of symptoms are assessed as outcome variables as per the Greene Climacteric Scale before treatment(0th day), during treatment for 30 days(31st day) and after follow up for 30 days without medication (61st day)

Psychological symptoms

Time Frame: Changes in the level of symptoms are assessed as outcome variables as per the Greene Climacteric Scale before treatment(0th day), during treatment for 30 days(31st day) and after follow up for 30 days without medication (61st day)

Somatic symptoms

Time Frame: Changes in the level of symptoms are assessed as outcome variables as per the Greene Climacteric Scale before treatment(0th day), during treatment for 30 days(31st day) and after follow up for 30 days without medication (61st day)

Vasomotor symptoms

Time Frame: Changes in the level of symptoms are assessed as outcome variables as per the Greene Climacteric Scale before treatment(0th day), during treatment for 30 days(31st day) and after follow up for 30 days without medication (61st day)

Secondary Outcomes

  • Pharmacognostical, phytochemical, HPTLC & Ayurvedic parameters(Rasa, Guna, Virya & Vipaka) of Talamuli(Curculigo orchioides Gaertn.)Rhizome & Talamuli choorna.(15 days before commencement of the study.)

Investigators

Sponsor
Rinsha Shareef
Sponsor Class
Other [PG Scholar Government Ayurveda College Tripunithura]
Responsible Party
Principal Investigator
Principal Investigator

RINSHA SHAREEF

Government Ayurveda College Tripunithura

Study Sites (1)

Loading locations...

Similar Trials